{
    "id": 26597,
    "fullName": "EGFR K745_E746insTPVAIK",
    "impact": "insertion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR K745_E746insTPVAIK is an exon 19 mutation that results in the insertion of six amino acids in the protein kinase domain of the Egfr protein between amino acids 745 and 746 (UniProt.org). K745_E746insTPVAIK results in increased Egfr phosphorylation and is transforming in culture (PMID: 22190593).",
            "references": [
                {
                    "id": 439,
                    "pubMedId": 22190593,
                    "title": "EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22190593"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "K745_E746insTPVAIK",
    "createDate": "05/17/2017",
    "updateDate": "09/05/2018",
    "referenceTranscriptCoordinates": {
        "id": 135718,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55174772_55174773insACACCTGTAGCAATCAAG",
        "cDna": "c.2235_2236insACACCTGTAGCAATCAAG",
        "protein": "p.K745_E746insTPVAIK",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10915,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a lung adenocarcinoma patient harboring EGFR K745_E746insTPVAIK demonstrated a partial response when treated with Tarceva (erlotinib) (PMID: 22190593).",
            "molecularProfile": {
                "id": 27854,
                "profileName": "EGFR K745_E746insTPVAIK"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 439,
                    "pubMedId": 22190593,
                    "title": "EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22190593"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27854,
            "profileName": "EGFR K745_E746insTPVAIK",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135718,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55174772_55174773insACACCTGTAGCAATCAAG",
            "cDna": "c.2235_2236insACACCTGTAGCAATCAAG",
            "protein": "p.K745_E746insTPVAIK",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}